NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE167335 Query DataSets for GSE167335
Status Public on Feb 24, 2021
Title Gene expression profile of iPSC-derived dopaminergic neurons from control and Parkinson's disease patients carrying LRRK2 G2019S point mutation
Organism Homo sapiens
Experiment type Other
Summary The goal of this study is to compare the RNA expression profile from human iPSC-derived dopaminergic neurons from control, Parkinson’s disease LRRK2 G2019S and gene-edited isogenic lines (with corrected LRRK2 mutation) to gain insight into the mechanisms underlying neuronal degeneration in PD.
Total RNA was assayed for quantity and quality using Qubit® RNA HS Assay (Life Technologies) and RNA 6000 Nano Assay on a Bioanalyzer 2100. All the steps were carried out in the ice and using the nCounter nanoString reagent for the Neuropathology panel. The master mix for the hybridization process was prepared by mixing hybridization buffer and reporter CodeSet. A dilution of 10μg/μl for each RNA to be analyzed was prepared and maintained in ice. For each sample, a tube was prepared with 5μl of RNA (10μg/μl) and 8μl of master mix. 2μl of Capture ProbeSet was added in each tube and the hybridization process was started using a PCR machine at 65ºC for at least 16 hours. After this step, the samples were maintained at 4ºC. Once the hybridization process was completed, the hybridized RNA was loaded in the neuropathology cartridge, and the data were available 24 hours later.
 
Overall design Parkinson's disease (PD) human iPSC-derived neuronal expression profile was obtained by comparing human iPSC-derived neurons from control, PD LRRK2 G2019S patients and isogenic lines. MRNA profiles were generated using the nCounter nanoString reagent for Neuropathology panel. Control = from one healthy individual; 2 independent differentiations. PD = from 2 PD-LRRK2 G2019S patients; 2/3 independent differentiations; isoPD = from 2 corrected PD-LRRK2 patients; 2/3 independent differentations.
 
Contributor(s) Pons M
Citation(s) 34215735
Submission date Feb 23, 2021
Last update date Jul 27, 2021
Contact name Meritxell Pons
E-mail(s) meritxell.pons@ub.edu
Organization name IDIBELL
Lab Stem Cells and Neurodegeneration Lab
Street address Avinguda Gran Via, 199-203
City Hospitalet de Llobregat (Barcelona)
ZIP/Postal code 08908
Country Spain
 
Platforms (1)
GPL29761 Nanostring nCounter Human Neuropathology Panel
Samples (10)
GSM5102465 C1#1 TH D50 n1
GSM5102466 C1#1 TH D50 n2
GSM5102467 LL2_3THD50n1
Relations
BioProject PRJNA704331

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE167335_Analysis2_Gene_expression_analysis_D50_vmDAn_PD-PDiso_and_Control_NormalizedData.csv.gz 28.5 Kb (ftp)(http) CSV
GSE167335_RAW.tar 100.0 Kb (http)(custom) TAR (of RCC)
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap